Table 3.
Clinical and laboratory spectrum of thiazide-associated hypercalcemia among Olmsted County, Minnesota, residents, 1992-2001, overall and subset later found to have primary hyperparathyroidism
Characteristic | All patients mean ± SD, or n (%) | Primary Hyperparathyroidism subset mean ± SD, or n (%) |
---|---|---|
Female gender | 68 (94.4) | 19 (95.0) |
Age at onset of hypercalcemia, yrs | 63.9 ± 11.3 | 66.2 ± 11.2 |
Serum calcium prior to thiazide use, mg/dL | 9.7 ± 0.4 | 9.7 ± 0.5 |
Maximum serum calcium on thiazides, mg/dL | 10.7 ± 0.3 | 11.0 ± 0.4 |
Serum parathyroid hormone, pmol/L | 4.8 ± 2.7 | 6.3 ± 4.4 |
Years from thiazide start to hypercalcemia | 6.0 ± 7.2 | 7.3 ± 8.5 |
Reason for thiazide use | ||
Hypertension | 68 (94.4) | 20 (100) |
Edema | 2 (2.8) | 0 (0) |
Hypercalciuria/nephrolithiasis | 2 (2.8) | 0 (0) |